Effect of Dietary Carbohydrate Content and Inulin-Fructooligosaccharide Supplementation on Glycemic Control in Individuals With Type 1 Diabetes Mellitus
1 other identifier
interventional
30
1 country
1
Brief Summary
Diabetes is a chronic metabolic disease in which nutrients such as carbohydrates, fats and proteins cannot be utilized sufficiently due to the inability to produce insulin or defects in the effect of the produced insulin. The risk of individuals encountering complications related to diabetes decreases when glycemic control is achieved in these patients. Therefore, nutrition is an necessary component of treatment. Although there are many studies in the literature examining the effect of carbohydrate intake on glycemic control in individuals with diabetes and monitoring carbohydrate intake in individuals with diabetes is the basic strategy for reaching glucose targets, a common denominator has not yet been reached for the optimal amount of carbohydrate intake for individuals with diabetes. There are a wide range of definitions regarding carbohydrate intake and studies on carbohydrate restriction, especially in individuals with Type 1 diabetes, are limited. In present randomized controlled crossover study, three isocaloric different dietary treatment are planned to applied for 2 weeks in which (i) 30% of the daily energy requirement is provided from carbohydrates, not to fall below 130 g/day carbohydrates according to the individual characteristics of the patients, (ii) 50-55% of the daily energy requirement is provided from carbohydrates and (iii) carbohydrate content in the diet is adjusted without increasing the amount of carbohydrates, by supplementing 2 sachets (1 sachet 3.68 g inulin + 3.68 g ) where 50-55% of daily energy requirement is provided from carbohydrates together with fructooligosaccharide (FOS)) inulin fructooligosaccharide (FOS) supplementation. A 2-week washout period is planned between each diet model. The research will be conducted with 20 individuals with Type 1 diabetes using a Continuous Glucose Monitoring device. The proposed project aims to investigate the effect of different dietary treatments on glycemic control in individuals with Type 1 diabetes by using a continuous glucose measuring device. At the end of each dietary treatment application, the data obtained from the Continuous Glucose Measuring Device will be evaluated as the primary outcomes; total insulin dose, insulin/Carbohydrate ratio, total bolus insulin dose will be evaluated as the secondary outcomes. As a result of the research, the potential effects of different dietary treatments on glycemic control will be evaluated and the development of the most appropriate diet model for these patients will be contributed. In addition, this research will contribute to the improvement of the continuous glucose monitoring device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 11, 2026
CompletedFirst Submitted
Initial submission to the registry
June 23, 2026
CompletedFirst Posted
Study publicly available on registry
June 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 27, 2026
CompletedJune 29, 2026
May 1, 2026
2 months
June 23, 2026
June 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Continuous Glucose Measuring Device Measurements
From the enrollment to the end of treatment at 8 weeks
Secondary Outcomes (1)
Other measurements
From the enrollment to the end of the treatment at 12 weeks
Study Arms (3)
30% of the daily energy requirement is provided from carbohydrates, not to fall below 130 g/day carb
EXPERIMENTAL50-55% of the daily energy requirement is provided from carbohydrates
EXPERIMENTALcarbohydrate content in the diet is adjusted without increasing the amount of carbohydrates, by supp
EXPERIMENTALInterventions
Carbohydrate content of diet
Dietary carbohydrate is 30% of daily energy requirements
Dietary carbohydrate is 50-55% of daily energy requirements
Eligibility Criteria
You may qualify if:
- Patients aged 18-65 years diagnosed with Type 1 diabetes and currently using a Continuous Glucose Monitoring device
You may not qualify if:
- Individuals with type 2 diabetes
- Individuals with gestational diabetes
- Breastfeeding individuals
- Individuals with celiac disease
- Individuals with gastroparesis
- Renal insufficiency (tGFR ≤ 60 ml/min/1.73 m2)
- Diagnosed liver failure
- Immunodeficiency
- Individuals with malignancy
- Using nutritional supplements that may affect metabolic parameters
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 23, 2026
First Posted
June 29, 2026
Study Start
May 11, 2026
Primary Completion
July 20, 2026
Study Completion
July 27, 2026
Last Updated
June 29, 2026
Record last verified: 2026-05